Please see the first issue of OIS Press with updates on novel ophthalmic therapies. I provide a perspective in recent US FDA approvals (Pages 9 and 11).
- University of California Library and Elsevier Continue to Disagree
- NDA Partners Featured in Article on Growth of Pharma Disruptors
- Predatory journals – just say no!
- Sonoma Eye – Dr. Novack chair symposium on research and outcomes
- Pinterest takes a move AGAINST anti-science movement.
- U.S. FDA strengthens regulation of dietary supplements